Benzinga | Aug 17, 2021 04:03PM EDT

Cue Biopharma Q2 EPS $(0.33) Beats $(0.42) Estimate, Sales $2.74M Beat $1.06M Estimate

Cue Biopharma (NASDAQ:CUE) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0.42) by 21.43 percent. This is a 13.16 percent increase over losses of $(0.38) per share from the same period last year. The company reported quarterly sales of $2.74 million which beat the analyst consensus estimate of $1.06 million by 158.40 percent. This is a 154.79 percent increase over sales of $1.07 million the same period last year.